These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16352861)

  • 1. Special feature: cardiovascular-kidney interactions in health and disease.
    Wilcox CS
    Am J Physiol Regul Integr Comp Physiol; 2006 Jan; 290(1):R34-6. PubMed ID: 16352861
    [No Abstract]   [Full Text] [Related]  

  • 2. Sex and gender differences in cardiovascular-renal physiology and pathophysiology.
    Reckelhoff JF; Maric C
    Steroids; 2010 Nov; 75(11):745-6. PubMed ID: 20595039
    [No Abstract]   [Full Text] [Related]  

  • 3. Papers presented at the Cardiovascular Kidney Investigators Meeting, Amelia Island, Florida, USA, May 28-31, 2004.
    Am J Physiol Heart Circ Physiol; 2005 Jan; 288(1):H3-68. PubMed ID: 15761991
    [No Abstract]   [Full Text] [Related]  

  • 4. Physiology in perspective: addressing cardiovascular health and disease.
    Sieck G
    Physiology (Bethesda); 2013 Jul; 28(4):214-5. PubMed ID: 23817795
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of urotensin II in cardiovascular and renal physiology and diseases.
    Zhu YC; Zhu YZ; Moore PK
    Br J Pharmacol; 2006 Aug; 148(7):884-901. PubMed ID: 16783414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endothelins: a new family of peptides with biologic effects. Which is their physiopathologic role?].
    Fontana F; Bernardi P; Lenzi S
    G Ital Cardiol; 1993 Jun; 23(6):599-609. PubMed ID: 8405822
    [No Abstract]   [Full Text] [Related]  

  • 7. A simple model for demonstrating the factors affecting glomerular filtration rate.
    Bhaskar A; Oommen V
    Adv Physiol Educ; 2018 Jun; 42(2):380-382. PubMed ID: 29761711
    [No Abstract]   [Full Text] [Related]  

  • 8. [Renal function in the aged].
    Migliori V; Matarazzo V; Bonazzi A; Morabito F; Cuppini S
    G Clin Med; 1976; 57(9-10):311-22. PubMed ID: 1027655
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of obesity on cardiovascular health.
    Chrostowska M; Szyndler A; Hoffmann M; Narkiewicz K
    Best Pract Res Clin Endocrinol Metab; 2013 Apr; 27(2):147-56. PubMed ID: 23731877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of endothelin in the pathogenesis of renal and cardiovascular diseases].
    Wiecek A; Szurkowski M
    Pol Arch Med Wewn; 1992 Nov; 88(5):330-5. PubMed ID: 1300553
    [No Abstract]   [Full Text] [Related]  

  • 11. Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia?
    Rump LC; Amann K; Orth S; Ritz E
    Nephrol Dial Transplant; 2000 Nov; 15(11):1735-8. PubMed ID: 11071955
    [No Abstract]   [Full Text] [Related]  

  • 12. [Kidney and cardiovascular disease: are the predictive equations of glomerular filtration useful?].
    Fontseré Baldellou N
    Med Clin (Barc); 2007 Nov; 129(18):697-8. PubMed ID: 18021611
    [No Abstract]   [Full Text] [Related]  

  • 13. Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases.
    Eto T; Kitamura K; Kato J
    Clin Exp Pharmacol Physiol; 1999; 26(5-6):371-80. PubMed ID: 10386225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of orthostatism on circulation and kidney function in cardiacs].
    HIMBERT J; SCEBAT L; KREMER R
    Sem Hop; 1956 Feb; 32(8):423-30. PubMed ID: 13353886
    [No Abstract]   [Full Text] [Related]  

  • 15. Endothelins in the control of cardiovascular and renal function.
    Remuzzi G; Benigni A
    Lancet; 1993 Sep; 342(8871):589-93. PubMed ID: 8102724
    [No Abstract]   [Full Text] [Related]  

  • 16. [Progress in physiopathology].
    Orlowski Z
    Pol Arch Med Wewn; 1966; 37(3):341-6. PubMed ID: 5332884
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease.
    Ingelfinger JR
    Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):79-84. PubMed ID: 19077694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of nonproteolytic activation of prorenin.
    Susic D; Lippton H; Knight M; Frohlich ED
    Hypertension; 2006 Dec; 48(6):e113; author reply e114. PubMed ID: 17043161
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular, Renal and Metabolic Diseases: Physiology and Gender.
    Physiologist; 2016 Jan; 59(1):43-6. PubMed ID: 26852616
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of exercise on cardiovascular and renal function in cardiac patients with and without heart failure.
    JUDSON WE; HOLLANDER W; HATCHER JD; HALPERIN MH
    J Clin Invest; 1955 Oct; 34(10):1546-58. PubMed ID: 13263435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.